0000899243-18-009413.txt : 20180404
0000899243-18-009413.hdr.sgml : 20180404
20180404133353
ACCESSION NUMBER: 0000899243-18-009413
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180402
FILED AS OF DATE: 20180404
DATE AS OF CHANGE: 20180404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: V-Sciences Investments Pte Ltd
CENTRAL INDEX KEY: 0001379350
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38433
FILM NUMBER: 18736617
BUSINESS ADDRESS:
STREET 1: 60B ORCHARD ROAD #06-18
STREET 2: THE ATRIUM@ORCHARD
CITY: SINGAPORE
STATE: U0
ZIP: 238891
BUSINESS PHONE: 0116568286762
MAIL ADDRESS:
STREET 1: 60B ORCHARD ROAD #06-18
STREET 2: THE ATRIUM@ORCHARD
CITY: SINGAPORE
STATE: U0
ZIP: 238891
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Temasek Holdings (Private) Ltd
CENTRAL INDEX KEY: 0001021944
FISCAL YEAR END: 0331
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38433
FILM NUMBER: 18736621
BUSINESS ADDRESS:
STREET 1: 60B ORCHARD ROAD #06-18 TOWER 2
STREET 2: THE ATRIUM@ORCHARD
CITY: SINGAPORE
STATE: U0
ZIP: 238891
BUSINESS PHONE: 65 6828 6828
MAIL ADDRESS:
STREET 1: 60B ORCHARD ROAD #06-18 TOWER 2
STREET 2: THE ATRIUM@ORCHARD
CITY: SINGAPORE
STATE: U0
ZIP: 238891
FORMER NAME:
FORMER CONFORMED NAME: TEMASEK HOLDINGS (PRIVATE) LTD
DATE OF NAME CHANGE: 20050912
FORMER NAME:
FORMER CONFORMED NAME: TEMASEK HOLDINGS LTD
DATE OF NAME CHANGE: 19960829
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TLS Beta Pte. Ltd.
CENTRAL INDEX KEY: 0001673754
STATE OF INCORPORATION: U0
FISCAL YEAR END: 0331
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38433
FILM NUMBER: 18736618
BUSINESS ADDRESS:
STREET 1: 60B ORCHARD ROAD #06-18
STREET 2: THE ATRIUM@ORCHARD
CITY: SINGAPORE
STATE: U0
ZIP: 238891
BUSINESS PHONE: 65-6828-6828
MAIL ADDRESS:
STREET 1: 60B ORCHARD ROAD #06-18
STREET 2: THE ATRIUM@ORCHARD
CITY: SINGAPORE
STATE: U0
ZIP: 238891
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Temasek Life Sciences Private Ltd
CENTRAL INDEX KEY: 0001379349
STATE OF INCORPORATION: U0
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38433
FILM NUMBER: 18736619
BUSINESS ADDRESS:
STREET 1: 60B ORCHARD ROAD #06-18
STREET 2: THE ATRIUM@ORCHARD
CITY: SINGAPORE
STATE: U0
ZIP: 238891
BUSINESS PHONE: 0116568286762
MAIL ADDRESS:
STREET 1: 60B ORCHARD ROAD #06-18
STREET 2: THE ATRIUM@ORCHARD
CITY: SINGAPORE
STATE: U0
ZIP: 238891
FORMER NAME:
FORMER CONFORMED NAME: Temasek Life Sciences Private LTD
DATE OF NAME CHANGE: 20061027
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fullerton Management Pte Ltd
CENTRAL INDEX KEY: 0001379348
STATE OF INCORPORATION: U0
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38433
FILM NUMBER: 18736620
BUSINESS ADDRESS:
STREET 1: 60B ORCHARD ROAD #06-18 TOWER 2
STREET 2: THE ATRIUM@ORCHARD
CITY: SINGAPORE
STATE: U0
ZIP: 238891
BUSINESS PHONE: 65 6828 6586
MAIL ADDRESS:
STREET 1: 60B ORCHARD ROAD #06-18 TOWER 2
STREET 2: THE ATRIUM@ORCHARD
CITY: SINGAPORE
STATE: U0
ZIP: 238891
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Homology Medicines, Inc.
CENTRAL INDEX KEY: 0001661998
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473468154
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 45 WIGGINS AVE.
CITY: BEDFORD
STATE: MA
ZIP: 01730
BUSINESS PHONE: 857-305-1825
MAIL ADDRESS:
STREET 1: 45 WIGGINS AVE.
CITY: BEDFORD
STATE: MA
ZIP: 01730
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-04-02
1
0001661998
Homology Medicines, Inc.
FIXX
0001021944
Temasek Holdings (Private) Ltd
60B ORCHARD ROAD #06-18
TOWER 2, THE ATRIUM@ORCHARD
SINGAPORE
U0
238891
SINGAPORE
0
0
1
0
0001379348
Fullerton Management Pte Ltd
60B ORCHARD ROAD #06-18
TOWER 2, THE ATRIUM@ORCHARD
SINGAPORE
U0
238891
SINGAPORE
0
0
1
0
0001379349
Temasek Life Sciences Private Ltd
60B ORCHARD ROAD #06-18
TOWER 2, THE ATRIUM@ORCHARD
SINGAPORE
U0
238891
SINGAPORE
0
0
1
0
0001673754
TLS Beta Pte. Ltd.
60B ORCHARD ROAD #06-18
TOWER 2, THE ATRIUM@ORCHARD
SINGAPORE
U0
238891
SINGAPORE
0
0
1
0
0001379350
V-Sciences Investments Pte Ltd
60B ORCHARD ROAD #06-18
TOWER 2, THE ATRIUM@ORCHARD
SINGAPORE
U0
238891
SINGAPORE
0
0
1
0
Common Stock
2018-04-02
4
C
0
1605681
A
1605681
I
See footnote
Common Stock
2018-04-02
4
C
0
989612
A
2595293
I
See footnote
Common Stock
2018-04-02
4
P
0
625000
16.00
A
3220293
I
See footnote
Series A Preferred Stock
2018-04-02
4
C
0
1605681
D
Common Stock
1605681
0
I
See footnotes
Series B Preferred Stock
2018-04-02
4
C
0
989612
D
Common Stock
989612
0
I
See footnotes
The Series A Preferred Stock of Homology Medicines, Inc. (the "Issuer") held of record by TLS Beta Pte. Ltd. ("TLS Beta") automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the initial public offering of the Issuer. Pursuant to the Amended and Restated Certificate of Incorporation of the Issuer, the shares of Series A Preferred Stock had been convertible, at the option of the holder, at any time into shares of Common Stock at an initial conversion rate equal to one share of Common Stock per share of Series A Preferred Stock, subject to adjustment and had no expiration date.
The Series B Preferred Stock of the Issuer held of record by TLS Beta automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the initial public offering of the Issuer. Pursuant to the Amended and Restated Certificate of Incorporation of the Issuer, the shares of Series B Preferred Stock had been convertible, at the option of the holder, at any time into shares of Common Stock at an initial conversion rate equal to one share of Common Stock per share of Series B Preferred Stock, subject to adjustment and had no expiration date.
Consists of 1,605,681 shares of Common Stock held of record by TLS Beta.
Consists of 989,612 shares of Common Stock held of record by TLS Beta.
Consists of 625,000 shares of Common Stock held of record by V-Sciences Investments Pte Ltd ("V-Sciences") which were purchased in the Issuer's initial public offering at a price of $16.00 per share. V-Sciences Investments Pte Ltd is a direct wholly-owned subsidiary of Temasek Life Sciences Private Limited. Temasek Life Sciences Private Limited ("TLS") is a direct wholly-owned subsidiary of Fullerton Management Pte Ltd ("FMPL"), which in turn is a direct wholly-owned subsidiary of Temasek Holdings (Private) Limited ("Temasek"). TLS, FMPL and Temasek may therefore be deemed to have or share beneficial ownership of the securities held by V-Sciences.
TLS Beta is a direct wholly-owned subsidiary of TLS. TLS is a direct wholly-owned subsidiary of FMPL, which in turn is a direct wholly-owned subsidiary of Temasek. TLS, FMPL and Temasek may therefore be deemed to have or share beneficial ownership of the securities held by TLS Beta.
Temasek Holdings (Private) Limited, By: /s/Christina Choo, Authorized Signatory
2018-04-04
Fullerton Management Pte Ltd, By: /s/ Cheong Kok Tim, Director
2018-04-04
Temasek Life Sciences Private Limited, By: /s/ Lim Siew Lee Sherlyn, Director
2018-04-04
TLS Beta Pte. Ltd., By: /s/ Christina Choo, Director
2018-04-04
V-Sciences Investments Pte Ltd, By: /s/ Christina Choo, Director
2018-04-04